Abbott Spinal Stimulator MDL: What Georgians Face in 2026

Sarah, a lively 45-year-old from Brookhaven, Georgia, had always been active, but a persistent lower back injury from a car accident in 2022 left her with chronic pain that medication could no longer manage. Her doctors recommended a spinal cord stimulator, suggesting it could restore her quality of life. She opted for an Abbott device, hoping for relief, but instead, she found herself plunged into a complex legal battle as issues with the device mounted, in the end leading to an Abbott device MDL.

The Promise and Peril of Neuromodulation

Spinal cord stimulators (SCS) represent a significant advancement in pain management, offering hope for individuals like Sarah who haven’t found relief through conventional treatments. These devices deliver mild electrical pulses to the spinal cord, masking pain signals before they reach the brain. For many, they work as intended, providing a renewed sense of normalcy. However, for a growing number of patients, the promise has turned into a prolonged nightmare of complications, additional surgeries, and persistent pain.

Abbott Laboratories, a prominent medical device manufacturer, produces several lines of spinal cord stimulators, including the Proclaim and BurstDR systems. While these devices have helped countless patients, reports of malfunctions and adverse events began to accumulate in recent years. These issues range from lead migration, where the implanted wires shift out of place, to battery failures requiring premature replacement, and even more severe complications like infections, neurological damage, and ineffective pain relief. Sarah experienced sudden, sharp jolts of pain that she described as “electrical shocks” radiating down her leg, far worse than her original discomfort. Her device, an Abbott Proclaim XR, was supposed to be a long-term solution.

Injured in an accident?

Know what your case is worth with AI Injury Payout Calculator for FREE!

Start my free evaluation

The Genesis of a Multidistrict Litigation

As complaints mounted across the country, it became clear that individual lawsuits against Abbott would overwhelm the court system. This is where the concept of a Multidistrict Litigation (MDL) comes into play. An MDL is a special federal legal procedure designed to manage complex cases that involve numerous plaintiffs and similar legal questions against a common defendant. It centralizes pretrial proceedings, such as discovery and motions, before a single federal judge. This consolidation aims to promote efficiency, reduce costs for all parties, and ensure consistent rulings on common legal and factual issues. It differs from a class action, where a single lawsuit represents a group of people with similar injuries. In an MDL, each plaintiff retains their own individual lawsuit, even though they are consolidated for pretrial matters.

The Judicial Panel on Multidistrict Litigation (JPML) officially established the Abbott spinal cord stimulator MDL, known as In re: Abbott Laboratories, Inc., Spinal Cord Stimulator Products Liability Litigation, in the Northern District of Illinois. This decision, made in late 2024, brought together dozens of lawsuits, with more expected to join. The choice of the Northern District of Illinois is not arbitrary. Abbott has a significant corporate presence there, making it a logical jurisdiction for such a large-scale litigation. The presiding judge is tasked with overseeing the coordinated discovery process, which involves the exchange of evidence, documents, and depositions.

Sarah’s Journey Through the Legal Labyrinth

After months of escalating pain and repeated visits to her pain management specialist at Emory University Hospital Midtown in Atlanta, Sarah’s doctor confirmed that the leads of her Abbott device had indeed migrated. This required another invasive surgery to reposition them. The procedure was painful, and the recovery was slow, costing her weeks of work at her marketing job in Buckhead. Frustrated and in more pain than before, Sarah began researching her options. She discovered that her experience was not isolated.

She contacted a Georgia personal injury law firm that had experience with medical device litigation. The attorneys explained the MDL process to her, detailing how her individual claim would be part of the larger litigation. Her case, like many others, centered on allegations of design defects, manufacturing flaws, and inadequate warnings. Plaintiffs argue that Abbott either knew or should have known about the potential for these devices to fail or cause injury, and that they failed to adequately warn patients and doctors.

For Sarah, the inadequate warnings were particularly concerning. She recalled being given extensive information about the general risks of surgery, but not specific details about the high rate of lead migration or battery depletion that many patients were now reporting. Her legal team is focusing on whether Abbott provided sufficient warnings to both healthcare providers and patients about the specific risks associated with their spinal cord stimulators, as required by law. This aspect of product liability is governed by principles outlined in Georgia statutes, such as O.C.G.A. Section 51-1-11, which addresses product liability generally.

Common Allegations Against Abbott

The core of the lawsuits consolidated in the Abbott device MDL revolves around several key allegations:

• Lead Migration: This is one of the most frequently cited issues. The thin wires (leads) implanted near the spinal cord can shift from their intended position, leading to a loss of therapeutic effect, new pain, or even neurological damage. Repositioning or replacement surgeries are often necessary, carrying their own risks.
• Battery Failure/Depletion: Patients report batteries depleting much faster than expected, requiring additional surgeries to replace the pulse generator. These unexpected surgeries are not only costly but also carry risks of infection and other complications.
• Device Malfunction: This encompasses a range of issues, including sudden electrical shocks, intermittent therapy, or complete device failure, leaving patients without pain relief and often in worse condition than before.
• Infections: Any implanted medical device carries a risk of infection, but plaintiffs allege that the design or materials of Abbott’s devices may contribute to a higher-than-expected rate of post-implantation infections, necessitating device removal.
• Inadequate Warnings: A central theme is the claim that Abbott failed to properly warn patients and medical professionals about the full scope and likelihood of these adverse events.

These allegations are not merely anecdotal. They are supported by adverse event reports filed with the U.S. Food and Drug Administration (FDA). According to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database, there have been thousands of reports related to spinal cord stimulators, many of which involve Abbott devices, detailing lead fractures, device malfunctions, and adverse patient effects. Accessing and analyzing this data is a critical part of the discovery process in an MDL.

The Role of Expert Testimony and Medical Records

In any medical device lawsuit, especially one as complex as an MDL, expert testimony is paramount. Medical experts, engineers, and product design specialists provide important insights into whether a device was defectively designed, manufactured, or marketed. For Sarah’s case, her legal team is working with experts who can analyze the design of the Abbott Proclaim XR, compare it to industry standards, and determine if specific design choices contributed to lead migration. They will also review her extensive medical records, including surgical reports, imaging studies from Northside Hospital Atlanta, and physician notes, to establish a clear causal link between the device and her injuries.

Gathering complete medical documentation is not just helpful. It’s absolutely essential. Every doctor’s visit, every imaging report, every surgical note, and every prescription related to the device and subsequent complications helps build a strong case. Without clear evidence of injury and its direct connection to the device, a claim will struggle. This is where an experienced legal team guides plaintiffs through the often-overwhelming process of compiling and presenting this evidence effectively.

I find that many clients, understandably, are so focused on their recovery that they don’t always realize the importance of careful record-keeping during the initial stages of their injury. It’s a common oversight, but one that can significantly impact the strength of their claim down the line.

The Path Ahead for Plaintiffs in the MDL

The MDL process can be lengthy. After consolidation, the initial phase involves extensive discovery, where both sides exchange information and evidence. This can include depositions of Abbott employees, engineers, and executives, as well as the review of internal company documents related to device design, testing, and marketing. Following discovery, bellwether trials may occur. These are a small number of representative cases selected to go to trial, providing both sides with an indication of how juries might respond to the evidence and arguments. The outcomes of bellwether trials often inform settlement negotiations for the remaining cases.

For Sarah and other plaintiffs, the goal is to secure compensation for their damages. This includes not only medical expenses already incurred and anticipated future medical costs (such as additional surgeries, physical therapy, and pain management), but also lost wages due to time off work, pain and suffering, and loss of enjoyment of life. The emotional toll of chronic pain, repeated surgeries, and the feeling of betrayal by a device meant to help, cannot be overstated.

While the MDL centralizes many aspects, each individual plaintiff’s case is unique. The specific injuries, the type of Abbott device implanted, the timeline of events, and the financial impact will vary. Therefore, personalized legal representation remains critical, even within the larger MDL framework. Attorneys must understand the nuances of each client’s situation to advocate effectively for their specific damages.

What to Do if You Have an Abbott Spinal Cord Stimulator

If you or a loved one in Georgia has an Abbott spinal cord stimulator and has experienced complications or adverse events, it is imperative to take action. First, prioritize your health by consulting with your physician about any new or worsening symptoms. Document everything: symptoms, doctor visits, treatments, and any financial losses incurred. This detailed record will be invaluable. Second, seek legal advice from a law firm experienced in medical device product liability. They can assess your specific situation, determine if you are eligible to join the Abbott device MDL, and guide you through the complex legal process. They will also explain how these cases are typically handled on a contingency fee basis, meaning you don’t pay attorney fees unless they secure a settlement or verdict for you.

The legal field surrounding defective medical devices is constantly evolving, but the fundamental principle remains: manufacturers have a responsibility to produce safe products and adequately warn consumers of risks. When they fail in this duty, they must be held accountable. The MDL against Abbott represents a collective effort to seek that accountability and provide justice for those harmed.

For individuals in Georgia impacted by these devices, seeking timely legal counsel is a critical step toward understanding your rights and pursuing the compensation you deserve. The process is daunting, but with the right legal team, working through the complexities of an MDL becomes manageable.